Norton Rose Fulbright has advised Canadian cannabis company Khiron Life Sciences on the deal. Osborne Clarke has advised PharmaDrug, Inc..Khiron Life Sciences acquired all shares in…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
